Publications:50
Reymundo Lozano, MD, MS
About Me
Dr. Reymundo Lozano, Associate Professor of Psychiatry, Genetics and Genomic Sciences, and Pediatrics, is a pediatric and adult clinical geneticist with neurodevelopmental and aging research training. He has dedicated his research to better understanding the molecular basis neurodevelopmental disorders including autism and dementia. He will direct the Fragile X Syndrome (FXS) Clinic at Mount Sinai and specializes in the treatment of FXS, Kabuki syndrome, Wiedemann-Steiner syndrome and FOXP1. As a collaborator on several clinical trials in FXS and autism, Dr. Lozano is committed to finding targeted treatments. Dr. Lozano’s health care leadership goals are to create new models for delivering high quality, efficient, and cost-effective care in an increasingly changing environment lead by technological advances in genetics and communication. Dr. Lozano has consulted for genetic laboratories, pharmaceutical companies and other non-profit organizations. In the Department of Psychiatry, Dr. Lozano will be a critical part of the Seaver Autism Center team.
Language
English
Position
ASSOCIATE PROFESSOR | Genetics and Genomic Sciences, ASSOCIATE PROFESSOR | Artificial Intelligence and Human Health, ASSOCIATE PROFESSOR | Pediatrics
Clinical Focus
- Autism
- Fragile X Syndrome
Research
Health care delivery leadership
Autism and learning disability
FOXP1 and FOXP2 genes
Fragile X syndrome
Autism and learning disability
FOXP1 and FOXP2 genes
Fragile X syndrome
Publications
Selected Publications
- Knowledge, attitudes, and perspectives on gene therapy for Fragile X syndrome: results from two community and caregiver surveys. Vivian Chen, Marisa Vomvos, Anna De Sonia, Hilary Rosselot, Reymundo Lozano. Frontiers in Molecular Neuroscience
- Profile of Behavioral Comorbidities in Children With Fragile X Syndrome. Walter E. Kaufmann, Paul S. Horn, Stephanie M. Morris, Jean A. Frazier, Carrie Buchanan, Reymundo Lozano, Ryan S. Uy, Andrea L. Gropman, Barbara A. Haas-Givler, Mary Ann Morris, Patricia A. Evans, Richard E. Frye, Amy Esler, Holly K. Harris, Ave M. Lachiewicz, Jonathan D. Picker, Gary Feldman, Craig A. Erickson, David Hessl, Randi J. Hagerman, Carol M. Delahunty, Allan Reiss, Amy Lightbody, Deborah Barbouth, Dejan B. Budimirovic, Robyn A. Filipink, Nicole Tartaglia, Marcy Schuster, Walter E. Kaufmann, Stephanie L. Sherman, Amy L. Talboy, Milen Velinov, Elizabeth Berry-Kravis. Journal of Autism and Developmental Disorders
- The Aberrant Behavior Checklist for Fragile X Syndrome: A Qualitative Clinician Evaluation of Content Validity. Lindsay M. Oberman, Elizabeth Berry-Kravis, Dejan B. Budimirovic, Craig A. Erickson, Randi J. Hagerman, Holly K. Harris, David Hessl, Reymundo Lozano, Audrey Thurm, Nicole Tartaglia, James Tran, Walter E. Kaufmann. Journal of Child and Adolescent Psychopharmacology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Lozano has not yet completed reporting of industry relationships or has no industry relationships to report.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.